DICE Short Interest

DICE Therapeutics, Inc. (DICE) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $2.27B, listed on NASDAQ, employing roughly 71 people, carrying a beta of 0.00 to the broader market. DICE Therapeutics, Inc. Led by J. Kevin Judice, public since 2021-09-15.

Short interest is the total number of shares currently sold short and not yet covered, reported bi-monthly by FINRA. Days to cover (short interest divided by average daily volume) indicates how long it would take short sellers to close positions, with higher values signaling greater squeeze potential.

Settlement Date

2026-09-15

Short Interest

9.2K

Previous Short Interest

0

Change

100.00%

Days to Cover

5.29

Avg Daily Volume

1.7K

Avg Days to Cover (24 reports)

11.94

Showing 24 bi-monthly FINRA short interest reports for DICE Therapeutics, Inc..

Learn how short interest is reported and how to read the data →